Met-MDS 100mg Injection

About

Met-MDS 100mg Injection is a crucial hypomethylating agent specifically indicated for the treatment of myelodysplastic syndromes (MDS) and certain forms of acute myeloid leukemia (AML) with MDS-related changes. Its therapeutic efficacy stems from its ability to inhibit DNA methyltransferases, a family of enzymes responsible for adding methyl groups to DNA. This inhibition leads to global DNA hypomethylation, a process that can reactivate silenced tumor suppressor genes and restore normal gene expression patterns critical for proper cellular differentiation and proliferation. By reversing aberrant methylation, Met-MDS aims to improve the dysfunctional hematopoiesis characteristic of MDS, leading to improved blood counts across all lineages (red blood cells, white blood cells, and platelets). This can significantly reduce the patient's dependence on blood transfusions, mitigate disease progression, and potentially extend overall survival, offering a vital treatment option for these challenging hematological malignancies.

Uses

• Treatment of myelodysplastic syndromes (MDS).
• Management of acute myeloid leukemia (AML) with MDS-related changes.
• Improvement of hematological parameters in high-risk MDS.
• Reduction of transfusion dependence in MDS patients.

Directions For Use

This medication is administered by a healthcare professional as a subcutaneous or intravenous injection. The treatment cycle and duration will be determined by your doctor.

Benefits

• Improves blood cell counts (red blood cells, white blood cells, platelets).
• Reduces the need for blood transfusions.
• May delay progression to acute myeloid leukemia.
• Enhances quality of life for MDS patients.
• Offers a targeted therapy for specific hematological malignancies.
• Contributes to disease stabilization and potential remission.

Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Fatigue
• Fever
• Injection site reactions (pain, erythema)
• Myelosuppression (low blood counts)
• Anemia
• Thrombocytopenia
• Neutropenia
• Pneumonia

Safety Measures

• Alcohol - Avoid or limit alcohol consumption, as it may exacerbate liver toxicity or other side effects.
• Pregnancy - Contraindicated during pregnancy due to significant risk of fetal harm. Women of childbearing potential must use effective contraception.
• Breastfeeding - Discontinue breastfeeding during treatment and for a period after the last dose due to potential harm to the infant.
• Liver - Use with caution in patients with severe liver impairment; dose adjustments may be necessary.
• Kidney - Use with caution in patients with renal impairment; dose adjustments may be necessary.
• Lung - Monitor for new or worsening pulmonary symptoms, as interstitial lung disease has been reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.